Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Atopic Dermatitis”

466 trials

Showing 20 of 466 results

Large-scale testing (Phase 3)Study completedNCT05369403
What this trial is testing

Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 86
Large-scale testing (Phase 3)Study completedNCT04875169
What this trial is testing

Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Reistone Biopharma Company Limited 336
Not applicableStudy completedNCT05969730
What this trial is testing

Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Mazandaran University of Medical Sciences 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05509023
What this trial is testing

Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)

Who this might be right for
Atopic Dermatitis
Q32 Bio Inc. 102
Not applicableStudy completedNCT06421740
What this trial is testing

An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China

Who this might be right for
Atopic Dermatitis
AbbVie 1,000
Not applicableStudy completedNCT07599878
What this trial is testing

Adjunctive Group Psychotherapy for Moderate-to-Severe Atopic Dermatitis: A Pilot Feasibility Study Comparing Two Interventions

Who this might be right for
Atopic Dermatitis
Semmelweis University 32
Post-approval studies (Phase 4)Study completedNCT03667014
What this trial is testing

The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients

Who this might be right for
Atopic DermatitisAtopic Dermatitis Eczema
University of California, San Francisco 34
Large-scale testing (Phase 3)Study completedNCT05899816
What this trial is testing

A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)

Who this might be right for
Atopic DermatitisModerate-to-severe Atopic Dermatitis
Amgen 221
Large-scale testing (Phase 3)Study completedNCT06173284
What this trial is testing

Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 519
Not applicableStudy completedNCT07577921
What this trial is testing

Evaluation of the Efficacy of a Cosmetic Care in Subjects With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments

Who this might be right for
Atopic Dermatitis
Pierre Fabre Dermo Cosmetique 80
Not applicableEnded earlyNCT05250115
What this trial is testing

Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 112
Testing effectiveness (Phase 2)Study completedNCT05375955
What this trial is testing

Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Who this might be right for
Atopic DermatitisPlaque Psoriasis
Pfizer 263
Not applicableUnknownNCT03795506
What this trial is testing

TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)

Who this might be right for
Atopic Dermatitis Eczema
Imperial College London 96
Testing effectiveness (Phase 2)Study completedNCT04162899
What this trial is testing

A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Reistone Biopharma Company Limited 105
Not applicableStudy completedNCT05394792
What this trial is testing

An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab

Who this might be right for
Atopic Dermatitis
AbbVie 111
Large-scale testing (Phase 3)Active Not RecruitingNCT05559359
What this trial is testing

Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisEczema
Eli Lilly and Company 377
Testing effectiveness (Phase 2)Study completedNCT03915496
What this trial is testing

Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer 46
Testing effectiveness (Phase 2)Looking for participantsNCT06397911
What this trial is testing

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Oneness Biotech Co., Ltd. 114
Large-scale testing (Phase 3)Looking for participantsNCT06389136
What this trial is testing

Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Who this might be right for
Atopic Dermatitis
AbbVie 200
Large-scale testing (Phase 3)Study completedNCT03607422
What this trial is testing

Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)

Who this might be right for
Atopic Dermatitis
AbbVie 912
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation